Why there is still no screening test for ovarian cancer
A 200,000-woman trial found that screening caught more early-stage disease. It did not save lives — a result that explains why guidelines recommend against screening the general population.
An estrogen-metabolism lifestyle score tracked with lower breast and uterine cancer risk
Women whose habits aligned with a favorable estrogen-metabolism pathway had up to 61% lower endometrial cancer risk. The score explains only a tenth of the variation it predicts.
Guideline-consistent breast cancer surgery ranged from 13% to 82% by country
VENUSCANCER assembled individual records for 275,792 women from 103 cancer registries in 39 countries. The gaps it found are in what treatment women actually received, not only in whether they were diagnosed.